amitriptyline has been researched along with Bladder Pain Syndrome in 31 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amitriptyline is frequently used to treat patients with interstitial cystitis/painful bladder syndrome." | 9.14 | Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. ( Burks, DA; Cen, L; Chai, TC; FitzGerald, MP; Foster, HE; Hanno, PM; Kreder, KJ; Kusek, JW; Landis, JR; Lukacz, ES; Mayer, RD; Nickel, JC; Nyberg, LM; Payne, CK; Peters, KM; Propert, KJ; Yang, CC; Yang, W, 2010) |
| "We compared the effectiveness of intravesical combination treatment and intravesical treatment plus low-dose amitriptyline in patients with primary bladder pain syndrome (PBPS)." | 8.12 | The effect of intravesical cocktail therapy combined with low-dose amitriptyline on primary bladder pain syndrome. ( Abat, D; Altunkol, A; Gökalp, F, 2022) |
| "The European Society for the Study of Interstitial Cystitis (ESSIC) recommended that interstitial cystitis (IC) should be replaced by bladder pain syndrome (BPS), which focused more attention on the painful or discomfort feeling related to bladder and weakened the importance of cystoscopy in diagnosis process." | 5.40 | Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate? ( Ding, Q; Fang, Z; Sun, Y; Zheng, J, 2014) |
| "We are motivated by a randomized clinical trial evaluating the efficacy of amitriptyline for the treatment of interstitial cystitis and painful bladder syndrome in treatment-naïve patients." | 5.19 | Estimating the efficacy of an interstitial cystitis/painful bladder syndrome medication in a randomized trial with both non-adherence and loss to follow-up. ( Landis, JR; Propert, KJ; Yang, W, 2014) |
| "Amitriptyline is frequently used to treat patients with interstitial cystitis/painful bladder syndrome." | 5.14 | Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. ( Burks, DA; Cen, L; Chai, TC; FitzGerald, MP; Foster, HE; Hanno, PM; Kreder, KJ; Kusek, JW; Landis, JR; Lukacz, ES; Mayer, RD; Nickel, JC; Nyberg, LM; Payne, CK; Peters, KM; Propert, KJ; Yang, CC; Yang, W, 2010) |
| "We compared the effectiveness of intravesical combination treatment and intravesical treatment plus low-dose amitriptyline in patients with primary bladder pain syndrome (PBPS)." | 4.12 | The effect of intravesical cocktail therapy combined with low-dose amitriptyline on primary bladder pain syndrome. ( Abat, D; Altunkol, A; Gökalp, F, 2022) |
| "The addition of ALA/n-3 PUFAs to amitriptyline treatment in patients with VBD/PBS appears to improve outcomes and may allow for a lower dosage of amitriptyline, which may lead to fewer adverse effects." | 2.84 | Alpha Lipoic Acid Plus Omega-3 Fatty Acids for Vestibulodynia Associated With Painful Bladder Syndrome. ( Felice, R; Gambini, D; Graziottin, A; Murina, F, 2017) |
| "Amitriptyline was taken strictly at bedtime following an established self-titration protocol without a limitation of the maximum daily dosage." | 2.75 | Long-term results of amitriptyline treatment for interstitial cystitis. ( Hertle, L; van Ophoven, A, 2010) |
| " Patients were prospectively treated for 4 months with a self-titration protocol that allowed them to escalate drug dosage in 25 mg increments in 1 week-intervals (maximum dosage 100 mg)." | 2.71 | A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. ( Heinecke, A; Hertle, L; Pokupic, S; van Ophoven, A, 2004) |
| "Amitriptyline was received strictly at bedtime following an established self-titration protocol without a limitation of the maximum daily dose." | 2.71 | Long-term results of amitriptyline treatment for interstitial cystitis. ( Hertle, L; van Ophoven, A, 2005) |
| "Interstitial cystitis (IC) and bladder pain syndrome (BPS) are chronic conditions that can be debilitating for patients." | 2.58 | An evaluation of the pharmacotherapy for interstitial cystitis. ( Giusto, LL; Shoskes, DA; Zahner, PM, 2018) |
| "The so-called interstitial cystitis is a chronic pain syndrome rather than a purely end organ disease of the urinary bladder." | 2.44 | [The complexity of chronic pelvic pain exemplified by the condition currently called interstitial cystitis. Part 2: Treatment]. ( Binder, I; Rossbach, G; van Ophoven, A, 2008) |
| "Painful bladder syndrome/interstitial cystitis (PBS/IC) is a controversial subject." | 2.44 | What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis? ( Seth, A; Teichman, JM, 2008) |
| "Interstitial cystitis is an enigmatic and frustrating condition to manage as a physician and to cope with as a patient." | 2.44 | Interstitial cystitis. ( Jones, A; Kelada, E, 2007) |
| "Symptoms of interstitial cystitis can usually be successfully managed with heparinoid therapy to theoretically alter bladder urothelial abnormalities, and with oral medications to inhibit neural upregulation or to control mast cell dysfunction." | 2.44 | Rational approaches to the treatment of patients with interstitial cystitis. ( Evans, RJ; Moldwin, RM; Rosenberg, MT; Stanford, EJ, 2007) |
| "Interstitial cystitis/painful bladder syndrome is a chronic disease characterized by pain, frequency, urgency, and nocturia and diagnosed primarily in women." | 2.44 | Interstitial cystitis/painful bladder syndrome. ( Warren, JW, 2007) |
| "Physicians should keep the diagnosis of interstitial cystitis in mind for all patients presenting with pelvic pain or urinary symptoms." | 2.43 | Interstitial cystitis: a primary care perspective. ( Page, S; Parsons, CL; Rosenberg, M, 2005) |
| "The adjusted hazard ratio (HR) for maculopathy in PPS users was 2." | 1.72 | Risk of maculopathy with pentosan polysulfate sodium use. ( Bae, SS; Etminan, M; Kezouh, A; Maberley, D; Sodhi, M, 2022) |
| "Amitriptyline was prescribed to 223 women with IC/BPS, only 125 of which (56%) had a documented history of depression." | 1.72 | Do medication prescription patterns follow guidelines in a cohort of women with interstitial cystitis/bladder pain syndrome? ( Anger, JT; Barbour, KE; Bresee, C; De Hoedt, AM; Freedland, SJ; Kim, J; Tholemeier, LN, 2022) |
| "Current management of bladder pain syndrome (BPS) was evaluated through a prospective electronic questionnaire posted on three patient support groups and sent to all members on the British Society of Urogynaecology (BSUG) database." | 1.43 | An assessment of clinicians' and patients' experiences in the management of bladder pain syndrome. ( Khan, KS; Tirlapur, SA, 2016) |
| "The European Society for the Study of Interstitial Cystitis (ESSIC) recommended that interstitial cystitis (IC) should be replaced by bladder pain syndrome (BPS), which focused more attention on the painful or discomfort feeling related to bladder and weakened the importance of cystoscopy in diagnosis process." | 1.40 | Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate? ( Ding, Q; Fang, Z; Sun, Y; Zheng, J, 2014) |
| "Bladder pain syndrome/interstitial cystitis (BPS/IC) is a chronic disease with a significant impact on quality of life." | 1.39 | Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines. ( Engelhardt, P; Riedl, C; Schwarz, B, 2013) |
| "We report a case of a patient with interstitial cystitis." | 1.36 | [Interstitial cystitis. A challenge for the clinician]. ( Bruetman, JE; Comercio, LP; Finn, BC; González, M; Quezel, M; Young, P, 2010) |
| "Interstitial cystitis is associated with substantial costs and health care resource utilization." | 1.35 | Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis. ( Chen, A; Lunacsek, OE; Sand, PK; Stanford, EJ; Wan, GJ, 2008) |
| "Interstitial cystitis is a particular type of cystitis with clear urine, essentially observed in women." | 1.30 | [Interstitial cystitis]. ( Lépinard, V, 1998) |
| "Definitive diagnosis of interstitial cystitis requires cystoscopy and hydrodistention." | 1.30 | Irritative voiding symptoms: identifying the cause. ( Gormley, EA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 12 (38.71) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Abat, D | 1 |
| Altunkol, A | 1 |
| Gökalp, F | 1 |
| Bae, SS | 1 |
| Sodhi, M | 1 |
| Maberley, D | 1 |
| Kezouh, A | 1 |
| Etminan, M | 1 |
| Tholemeier, LN | 1 |
| Bresee, C | 1 |
| De Hoedt, AM | 1 |
| Barbour, KE | 1 |
| Kim, J | 1 |
| Freedland, SJ | 1 |
| Anger, JT | 2 |
| Şahin, MF | 1 |
| Özcan, R | 1 |
| Malak, A | 1 |
| Doğan, Ç | 1 |
| Yazıcı, CM | 1 |
| Özcan, M | 1 |
| Akgül, M | 1 |
| Murina, F | 1 |
| Graziottin, A | 1 |
| Felice, R | 1 |
| Gambini, D | 1 |
| Giusto, LL | 1 |
| Zahner, PM | 1 |
| Shoskes, DA | 1 |
| Sun, Y | 1 |
| Fang, Z | 1 |
| Ding, Q | 1 |
| Zheng, J | 1 |
| Riedl, C | 1 |
| Engelhardt, P | 1 |
| Schwarz, B | 1 |
| Kapelner, A | 1 |
| Krieger, A | 1 |
| Dancel, R | 1 |
| Mounsey, A | 1 |
| Handler, L | 1 |
| Tirlapur, SA | 1 |
| Khan, KS | 1 |
| Stanford, EJ | 2 |
| Chen, A | 1 |
| Wan, GJ | 1 |
| Lunacsek, OE | 1 |
| Sand, PK | 1 |
| Binder, I | 1 |
| Rossbach, G | 1 |
| van Ophoven, A | 4 |
| Seth, A | 1 |
| Teichman, JM | 2 |
| Sea, J | 1 |
| Hertle, L | 3 |
| Foster, HE | 1 |
| Hanno, PM | 1 |
| Nickel, JC | 1 |
| Payne, CK | 2 |
| Mayer, RD | 1 |
| Burks, DA | 1 |
| Yang, CC | 1 |
| Chai, TC | 1 |
| Kreder, KJ | 1 |
| Peters, KM | 1 |
| Lukacz, ES | 1 |
| FitzGerald, MP | 1 |
| Cen, L | 1 |
| Landis, JR | 3 |
| Propert, KJ | 3 |
| Yang, W | 2 |
| Kusek, JW | 2 |
| Nyberg, LM | 2 |
| Young, P | 1 |
| Finn, BC | 1 |
| González, M | 1 |
| Comercio, LP | 1 |
| Quezel, M | 1 |
| Bruetman, JE | 1 |
| Zabihi, N | 1 |
| Clemens, JQ | 1 |
| Saigal, CS | 1 |
| Rodriguez, LV | 1 |
| Pokupic, S | 1 |
| Heinecke, A | 1 |
| Rosenberg, M | 1 |
| Parsons, CL | 1 |
| Page, S | 1 |
| Kelada, E | 1 |
| Jones, A | 1 |
| Moldwin, RM | 2 |
| Evans, RJ | 1 |
| Rosenberg, MT | 1 |
| Warren, JW | 1 |
| Lépinard, V | 1 |
| Gormley, EA | 1 |
| Rovner, E | 1 |
| Brensinger, C | 1 |
| Wein, AJ | 1 |
| Foy, M | 1 |
| Kirkemo, A | 1 |
| Sievert, KD | 1 |
| Edenfeld, KD | 1 |
| Oberpenning, F | 1 |
| Piechota, HJ | 1 |
| Sant, GR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone, the Effect of Low Dose Naltrexone on Symptoms and Pain of Patients With Interstitial Cystitis/Painful Bladder Syndrome a Randomized Placebo-controlled Prospective Trial[NCT04313972] | Phase 4 | 2 participants (Actual) | Interventional | 2021-09-07 | Completed | ||
| A Randomized Multicenter Clinical Trial to Evaluate the Efficacy of Amitriptyline for the Treatment of Painful Bladder Syndrome (PBS) in Newly Diagnosed Patients[NCT00124306] | Phase 3 | 271 participants (Actual) | Interventional | 2005-02-28 | Completed | ||
| A Randomized Trial of Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome[NCT04401176] | Phase 2 | 58 participants (Actual) | Interventional | 2020-09-15 | Completed | ||
| Use of Preemptive Pudendal Nerve Block Prior to Hydrodistension for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-blinded, Randomized Control Trial[NCT02517996] | 18 participants (Actual) | Interventional | 2015-02-28 | Terminated (stopped due to Preliminary results were promising when interim analysis performed but terminated due to primary investigators left recruitment site.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"To determine the change in interstitial cystitis symptom index at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The IC symptom index questionnaire consists of 4 questions on IC symptoms. 2 of the questions have 6 answer choices ranging from 0-never, to 5-almost always. 1 question has 6 answer choices ranging from 0-never to 5-usually. 1 question has 7 answer choices ranging from 0-never to 6-5 or more times. The numerical score for each question are added together, with a minimum score of 0 and a maximum score of 21. A higher score indicates greater severity of IC symptoms." (NCT02517996)
Timeframe: Baseline, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 12.5 | 11.43 | 11.8 | 10 |
| Normal Saline | 10 | 9 | 8.67 | 5 |
"To determine the change in pain at 2 hours, 2 weeks, 6 weeks, and 3 months postoperatively in patients undergoing hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline) using the visual analog scale (VAS).~VAS consists of a 10cm horizontal line with the minimum endpoint labeled no pain (0) and maximum labeled worst pain ever (10). Patients placed a mark on the point that corresponds to the level of pain severity they felt. The cm distance from the low end of the VAS to the patient's mark is used as the numerical index of the intensity of pain. Pain scores of 3.0-5.4 cm are moderate, over 5.4 indicates severe pain." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | ||||
|---|---|---|---|---|---|
| Pre operative VAS score | Post operative VAS score | 2 week post operative VAS scores | 6 week post operative VAS score | 12 weeks post operative VAS score | |
| 1% Lidocaine | 3.125 | 3.75 | 2.7 | 3 | 2.6 |
| Normal Saline | 4.5 | 5 | 4.8 | 4.33 | 2 |
"To determine the change in pelvic urgency, pain and frequency (PUF) questionnaire at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The Pelvic Urgency, Pain, and Frequency Patient Symptom Scale asks 11 questions, 7 on PUF symptoms, 4 on how bothersome PUF symptoms are. Symptom questions include 3, 4, or 5 ranked answers, with higher answers indicating more voids, or greater frequency of pain. The bother questions each of 4 ranked answers from 0-never, to 3-always. The symptom score is added, the bother score is added, and then the total score is added. The total PUF score is then reported. The minimum score is 0 and the maximum score is 35, and a higher score indicates greater symptoms and higher bother from pelvic pain and frequency." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 22.63 | 18.83 | 18.2 | 17.2 |
| Normal Saline | 19 | 17.4 | 16.7 | 14 |
"To determine the change in problem index (O'Leary Sant) at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The IC problem index questionnaire consists of 4 questions on how much of a problem a patient's IC symptoms cause them. Each question has 5 answer choices ranging from 0-no problem, to 4-big problem. The numerical score for each question are added together, with a minimum score of 0 and a maximum score of 16. A higher score indicates that IC symptoms cause more problems for the patient." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 11.75 | 9.71 | 10 | 9.6 |
| Normal Saline | 9.43 | 8.6 | 7.33 | 6 |
10 reviews available for amitriptyline and Bladder Pain Syndrome
| Article | Year |
|---|---|
An evaluation of the pharmacotherapy for interstitial cystitis.
Topics: Amitriptyline; Antibodies, Monoclonal; Antidepressive Agents, Tricyclic; Cimetidine; Cystitis, Inter | 2018 |
[The complexity of chronic pelvic pain exemplified by the condition currently called interstitial cystitis. Part 2: Treatment].
Topics: Administration, Intravesical; Administration, Oral; Amitriptyline; Arginine; Botulinum Toxins, Type | 2008 |
What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?
Topics: Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Cystoscopy; Glycoproteins; Humans; | 2008 |
Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.
Topics: Administration, Intravesical; Amitriptyline; Child; Cimetidine; Cystitis, Interstitial; Diet Therapy | 2009 |
Interstitial cystitis: a primary care perspective.
Topics: Amitriptyline; Cystitis, Interstitial; Disease Progression; Humans; Hydroxyzine; Primary Health Care | 2005 |
Interstitial cystitis.
Topics: Amitriptyline; Analgesics; Anti-Bacterial Agents; BCG Vaccine; Behavior Therapy; Cyclosporine; Cysti | 2007 |
Rational approaches to the treatment of patients with interstitial cystitis.
Topics: Administration, Intravesical; Administration, Oral; Amitriptyline; Anesthetics, Local; Combined Moda | 2007 |
Interstitial cystitis/painful bladder syndrome.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; C | 2007 |
[Oral therapy of interstitial cystitis].
Topics: Administration, Oral; Amitriptyline; Analgesics; Anti-Inflammatory Agents; Cystitis, Interstitial; H | 2000 |
Interstitial cystitis: a pathophysiology and treatment update.
Topics: Administration, Intravesical; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive | 2002 |
6 trials available for amitriptyline and Bladder Pain Syndrome
| Article | Year |
|---|---|
Alpha Lipoic Acid Plus Omega-3 Fatty Acids for Vestibulodynia Associated With Painful Bladder Syndrome.
Topics: Adolescent; Adult; Amitriptyline; Analgesics, Non-Narcotic; Antioxidants; Cystitis, Interstitial; Do | 2017 |
Long-term results of amitriptyline treatment for interstitial cystitis.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Antineoplastic Combined Chemotherapy P | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Double-Blind Method; Female; | 2010 |
Estimating the efficacy of an interstitial cystitis/painful bladder syndrome medication in a randomized trial with both non-adherence and loss to follow-up.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Computer Simulation; Cystitis, Interstitial; Humans; Logist | 2014 |
A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Cystitis, Interstitial; Double-Blind Method; | 2004 |
Long-term results of amitriptyline treatment for interstitial cystitis.
Topics: Administration, Oral; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Cystitis, Inters | 2005 |
15 other studies available for amitriptyline and Bladder Pain Syndrome
| Article | Year |
|---|---|
The effect of intravesical cocktail therapy combined with low-dose amitriptyline on primary bladder pain syndrome.
Topics: Administration, Intravesical; Amitriptyline; Cystitis, Interstitial; Humans; Nocturia; Surveys and Q | 2022 |
Risk of maculopathy with pentosan polysulfate sodium use.
Topics: Amitriptyline; Cystitis, Interstitial; Humans; Macular Degeneration; Pentosan Sulfuric Polyester; Re | 2022 |
Do medication prescription patterns follow guidelines in a cohort of women with interstitial cystitis/bladder pain syndrome?
Topics: Amitriptyline; Chronic Pain; Cystitis, Interstitial; Drug Prescriptions; Female; Humans; Hydroxyzine | 2022 |
The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment.
Topics: Amitriptyline; COVID-19; Cystitis, Interstitial; Female; Humans; Male; Pandemics; Urinary Bladder, O | 2023 |
Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate?
Topics: Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Cystoscopy; Female; Humans; Male; M | 2014 |
Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines.
Topics: Amitriptyline; Austria; Cystitis, Interstitial; Economics, Pharmaceutical; Health Care Costs; Humans | 2013 |
Matching on-the-fly: sequential allocation with higher power and efficiency.
Topics: Algorithms; Amitriptyline; Biometry; Computer Simulation; Cystitis, Interstitial; Humans; Linear Mod | 2014 |
Medications for treatment of interstitial cystitis.
Topics: Adult; Amitriptyline; Cimetidine; Cystitis, Interstitial; Evidence-Based Medicine; Female; Humans; H | 2015 |
An assessment of clinicians' and patients' experiences in the management of bladder pain syndrome.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Cystitis, Interstitial; Cystoscopy; | 2016 |
Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Cystitis, Interstitial; Cystoscopy; Delivery of Heal | 2008 |
[Interstitial cystitis. A challenge for the clinician].
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Cystitis, Interstitial; Female; Humans | 2010 |
Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome.
Topics: Administration, Intravesical; Administration, Oral; Adrenergic Uptake Inhibitors; Adult; Aged; Amine | 2011 |
[Interstitial cystitis].
Topics: Administration, Topical; Amitriptyline; Anti-Inflammatory Agents; Anticoagulants; Antidepressive Age | 1998 |
Irritative voiding symptoms: identifying the cause.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Cystitis, I | 1999 |
Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.
Topics: Amitriptyline; Cohort Studies; Cystitis, Interstitial; Cystoscopy; Dilatation; Female; Food, Formula | 2000 |